The relationship between extent of thyroid cancer surgery and use of radioactive iodine

Annals of Surgery

Volumn 258, Issue 2, 2013, Pages 354-358

  Haymart, Megan R ^a   Banerjee, Mousumi ^b   Yang, Di ^b   Stewart, Andrew K ^c   Doherty, Gerard M ^e   Koenig, Ronald J ^a   Griggs, Jennifer J ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c AMERICAN COLLEGE OF SURGEONS   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

patterns of care; radioactive iodine; survey; thyroid cancer; thyroid surgery; treatment intensity

Indexed keywords

RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER SIZE; CANCER STAGING; DIFFERENTIATED THYROID CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; SURGEON; THYROID CANCER; THYROID SURGERY; THYROIDECTOMY;

ADULT; DATABASES, FACTUAL; FEMALE; HEALTH CARE SURVEYS; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECK DISSECTION; PHYSICIAN'S PRACTICE PATTERNS; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; UNITED STATES;

EID: 84880520021     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31826c8915     Document Type: Article

References (32)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-2167.
2. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009;115:3801-3807.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012:62:10-29.
4. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246:375-381; discussion 81-84.
5. Yu XM,Wan Y, Sippel RS, et al. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg. 2011;254:653-660.
6. Podnos YD, Smith DD, Wagman LD, et al. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope. J Surg Oncol. 2007;96:3-7.
7. Vaisman F, Shaha A, Fish S, et al. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer. Clin Endocrinol (Oxf). 2011; doi: 10.1111/j.1365-2265.2011.04002.x [Epub ahead of print].
8. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
9. Jonklaas J, Sarlis NJ, Litofsky D, et al.Outcomes of patientswith differentiated thyroid carcinoma following initial therapy. Thyroid. 2006;16:1229-1242.
10. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007;142:906-913; discussion 913e1-913e2.
11. Haymart MR, Banerjee M, Stewart AK, et al. Use of radioactive iodine for thyroid cancer. JAMA. 2011;306:721-728.
12. Dillman DA, ed. Mail and Internet Surveys: The Tailored Design Method. 2nd ed. New York, NY: Wiley; 2007.
13. Alderman AK, Hawley ST, Waljee J, et al. Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer. 2007;109:1715-1720.
14. Sirovich B, Gallagher PM, Wennberg DE, et al. Discretionary decision making by primary care physicians and the cost of U.S. health care. Health Aff (Millwood). 2008;27:813-823.
15. Dick AW, Sorbero MS, Ahrendt GM, et al. Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Natl Cancer Inst. 2011;103:92-104.
16. Katz SJ, Hawley ST, Abrahamse P, et al. Does it matter where you go for breast surgery?: Attending surgeon's influence on variation in receipt of mastectomy for breast cancer. Med Care. 2010;48:892-899.
17. Mazzaferri EL. What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)? Oncology (Williston Park). 2009;23:579-588.
18. Hay ID. Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best? World J Surg. 2010;34:1291-1293.
19. Ito Y, Masuoka H, Fukushima M, et al. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg. 2010;34:1285-1290.
20. Grant CS, Stulak JM, Thompson GB, et al. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg. 2010;34:1239-1246.
21. Hassanain M,Wexler M. Conservative management of well-differentiated thyroid cancer. Can J Surg. 2010;53:109-118.
22. Durante C, Attard M, TorlontanoM, et al. Identification and optimal postsurgical follow-up of patientswith very low-risk papillary thyroidmicrocarcinomas. J Clin Endocrinol Metab. 2010;95:4882-4888.
23. Lin HW, Bhattacharyya N. Survival impact of treatment options for papillary microcarcinoma of the thyroid. Laryngoscope. 2009;119:1983-1987.
24. Doi SA, Engel JM, Onitilo AA. Total thyroidectomy followed by postsurgical remnant ablation may improve cancer specific survival in differentiated thyroid carcinoma. Clin Nucl Med. 2010;35:396-399.
25. Barney BM, Hitchcock YJ, Sharma P, et al. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33:645-649.
26. Mendelsohn AH, Elashoff DA, Abemayor E, et al. Surgery for papillary thyroid carcinoma: Is lobectomy enough? Arch Otolaryngol Head Neck Surg. 2010;136:1055-1061.
27. Davies L, Welch HG. Thyroid cancer survival in the United States: Observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg. 2010;136:440-444.
28. Kim EY, Eisele DW, Goldberg AN, et al. Neck dissections in the United States from 2000 to 2006: Volume, indications, and regionalization. Head Neck. 2011;33:768-773.
29. Bonnet S, Hartl D, Leboulleux S, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: Implications for radioiodine treatment. J Clin Endocrinol Metab. 2009;94:1162-1167.
30. Hughes DT, White ML, Miller BS, et al. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery. 2010;148:1100-1106; discussion 1006-1007.
31. Jagsi R, Abrahamse P, Morrow M, et al. Coordination of breast cancer care between radiation oncologists and surgeons: A survey study. Int J Radiat Oncol Biol Phys. 2011;82:2072-2078.
32. Friese CR, Hawley ST, Griggs JJ, et al. Employment of nurse practitioners and physician assistants in breast cancer care. J Oncol Pract. 2010;6:312-316.